Role of the liver in the control of carbohydrate and lipid homeostasis

C Postic, R Dentin, J Girard - Diabetes & metabolism, 2004 - Elsevier
The liver plays a unique role in controlling carbohydrate metabolism by maintaining glucose
concentrations in a normal range over both short and long periods of times. In type 2 …

Molecular physiology of mammalian glucokinase

PB Iynedjian - Cellular and Molecular Life Sciences, 2009 - Springer
The glucokinase (GCK) gene was one of the first candidate genes to be identified as a
human “diabetes gene". Subsequently, important advances were made in understanding the …

Assessing the potential of glucokinase activators in diabetes therapy

FM Matschinsky - Nature reviews Drug discovery, 2009 - nature.com
Glucokinase, a unique isoform of the hexokinase enzymes, which are known to
phosphorylate d-glucose and other hexoses, was identified during the past three to four …

Glucokinase and molecular aspects of liver glycogen metabolism

L Agius - Biochemical Journal, 2008 - portlandpress.com
Conversion of glucose into glycogen is a major pathway that contributes to the removal of
glucose from the portal vein by the liver in the postprandial state. It is regulated in part by the …

Genistein and daidzein modulate hepatic glucose and lipid regulating enzyme activities in C57BL/KsJ-db/db mice

SA Park, MS Choi, SY Cho, JS Seo, UJ Jung, MJ Kim… - Life sciences, 2006 - Elsevier
This study examines whether anti-diabetic effects of genistein and daidzein are mediated by
hepatic glucose and lipid regulating enzyme activities in type 2 diabetic animals. Male …

Anti-diabetic effects of lemon balm (Melissa officinalis) essential oil on glucose-and lipid-regulating enzymes in type 2 diabetic mice

MJ Chung, SY Cho, MJH Bhuiyan, KH Kim… - British journal of …, 2010 - cambridge.org
The antioxidant activity of lemon balm (Melissa officinalis) essential oil (LBEO) on 2, 2-
diphenyl-1-picrylhydrazyl (DPPH) radicals and its hypoglycaemic effect in db/db mice were …

5-Aminoimidazole-4-Carboxamide-1-β-d-Ribofuranoside and Metformin Inhibit Hepatic Glucose Phosphorylation by an AMP-Activated Protein Kinase–Independent …

B Guigas, L Bertrand, N Taleux, M Foretz… - Diabetes, 2006 - Am Diabetes Assoc
AMP-activated protein kinase (AMPK) controls glucose uptake and glycolysis in muscle.
Little is known about its role in liver glucose uptake, which is controlled by glucokinase. We …

New hepatic targets for glycaemic control in diabetes

L Agius - Best Practice & Research Clinical Endocrinology & …, 2007 - Elsevier
Type-2 diabetes is associated with impaired glucose clearance by the liver in the
postprandial state, and with elevated glucose production in the post-absorptive state. New …

Glucokinase regulatory protein: a balancing act between glucose and lipid metabolism in NAFLD

Z Zhang, G Ji, M Li - Frontiers in Endocrinology, 2023 - frontiersin.org
Non-alcoholic fatty liver disease (NAFLD) is a common liver disease worldwide, affected by
both genetics and environment. Type 2 diabetes (T2D) stands as an independent …

A novel glucokinase activator modulates pancreatic islet and hepatocyte function

AM Efanov, DG Barrett, MB Brenner, SL Briggs… - …, 2005 - academic.oup.com
The glucose-sensing enzyme glucokinase (GK) plays a key role in glucose metabolism. We
report here the effects of a novel glucokinase activator, LY2121260. The activator enhanced …